Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

J. Lavalle‐González, Fernando; Januszewicz, Andrzej; A. Davidson, Jaime; Tong, C.; Qiu, R.; Canovatchel, William; Meininger, Gary

doi:10.1007/s00125-013-3039-1

Public

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

Published in Diabetologia • Sep 11, 2013

Authors:

Fernando J. Lavalle‐González

Andrzej Januszewicz

Jaime A. Davidson

Abstract

AIMS/HYPOTHESIS: The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with background metformin. METHODS: This randomised, double-blind, four-arm, parallel-group, Phase 3 study was conducted a...

Subject

Canagliflozin

Sitagliptin

Metformin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!